Opioids - As enacted, clarifies that a physician licensed in this state is the only healthcare provider authorized to prescribe a buprenorphine product for a FDA-approved use in recovery or medication-assisted treatment; revises criteria for providers not licensed in this state to prescribe a buprenorphine product for the treatment of opioid use disorder. - Amends TCA Title 33; Title 41; Title 53 and Title 63.

This bill restricts buprenorphine prescriptions for opioid addiction treatment to Tennessee-licensed physicians only. It creates a limited exception allowing out-of-state healthcare providers working in state or county jails to prescribe under strict conditions: requiring DEA registration, employment at correctional facilities, and adherence to approved treatment protocols. The law takes effect July 1, 2025. It directly affects prescribing practices in correctional facilities and general medical settings by clarifying who may legally prescribe these medications.